Two Danish Patients Suffer Brain Hemorrhages After Receiving AstroZeneca COVID-19 Vaccines

Two patients in Denmark have developed brain hemorrhages after being stuck with COVID-19 vaccines produced by the pharmaceutical giant AstraZeneca.

These individuals were reportedly health care staff members and developed the brain hemorrhages within 14 days of receiving the vaccine. One woman has died and the other is critically ill.

Previously, the AstraZeneca vaccines had been blamed for its recipients developing blood clots. This has prompted certain countries in Europe to temporarily halt distribution of the vaccine.

Big League Politics has reported on how Italy, France and Germany have dropped the AstraZeneca COVID-19 vaccine because of complications, including deaths, that have happened after its distribution:

Three European nations announced on Monday that they are banning AstraZeneca’s COVID-19 vaccine in their countries, at least temporarily, due to deaths and other complications.

German health minister Jens Spahn announced the “precautionary suspension” as part of the nation’s “open and transparent” COVID-19 vaccine regime. Italy and France quickly followed suit after Germany made the announcement…

Italy announced they would be suspending the AstraZeneca vaccine after a recent death made news and alarmed people throughout the country.

The Italian medicine authority AIFA announced the “precautionary and temporary measure” of the AstraZeneca vaccine and seized thousands of its doses from Piedmont to stop the poison from being distributed throughout the northern region.

While government officials in these countries seem to genuinely care about the health of their people more than Big Pharma’s profit margins, this is not the case in every nation throughout Europe.”

This is not good news for AstroZeneca as they are currently applying for emergency authorization from the U.S. Food and Drug Administration (FDA) for their vaccine. The FDA has not approved their COVID-19 vaccine at the present time.

AstroZeneca believes their vaccine’s 79 percent efficacy rate in preventing symptomatic cases of COVID-19 proves that the FDA should approve their shots.

“These findings reconfirm previous results observed in AZD1222 trials across all adult populations but it’s exciting to see similar efficacy results in people over 65 for the first time,” said Ann Falsey, professor of medicine at the University of Rochester School of Medicine, who was paid to lead the trial.

“This analysis validates the AstraZeneca COVID-19 vaccine as a much-needed additional vaccination option, offering confidence that adults of all ages can benefit from protection against the virus,” Falsey added.

Big Pharma wants these shots to be injected into as many people as possible to boost their profit margins. The public will ultimately bear the cost, with pharmaceutical giants exempted from liability, as a result of this frenzied vaccine push.

Our Latest Articles